B. Riley analyst Drew Crum lowered the firm’s price target on Cinemark (CNK) to $29 from $35 and keeps a Neutral rating on the shares. The firm reviewed 4Q25 and previews exhibitor earnings with a slightly more subdued but still positive outlook following a weak holiday box office, a reassessed film slate, and potential valuation pressure from Warner Bros. Discovery (WBD)-related developments, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK: